This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

Anthony DeBiase
. at Rockwell Automation


Anthony has over 14 years of experience in the life science industry focusing on process development, operational technology (OT) implementation, technology transfer, and cGMP manufacturing in biologics, cell therapies and regenerative medicine. He spent 9 years at Regeneron Pharmaceuticals developing advanced biologic manufacturing processes at pilot scale and transferring them to clinical manufacturing. Part of his role was developing and deploying OT systems including data historians, process monitoring displays, analytics and alarms, and knowledge management platforms. Ultimately, he led a team of engineers deploying novel process analytical technology solutions for advanced bioreactor monitoring and control. In his most recent role Anthony at the startup 3DBio Therapeutics he led process development, tech transfer and clinical manufacturing of a novel 3D-bioprinted platform. His team successfully manufactured one of the first-in-human 3D-bioprinted cellular cartilage constructs that was clinically implanted.

Agenda Sessions

  • Accelerating Commercialization and Improving Efficiency Across the Network Through Digital Transformation